Literature DB >> 16321794

A central role for ROS in the functional remodelling of L-type Ca2+ channels by hypoxia.

Chris Peers1, Jason L Scragg, John P Boyle, Ian M Fearon, Shafeena C Taylor, Kim N Green, Nicola J Webster, Martin Ramsden, Hugh A Pearson.   

Abstract

Periods of prolonged hypoxia are associated clinically with an increased incidence of dementia, the most common form of which is Alzheimer's disease. Here, we review recent studies aimed at providing a cellular basis for this association. Hypoxia promoted an enhanced secretory response of excitable cells via formation of a novel Ca2+ influx pathway associated with the formation of amyloid peptides of Alzheimer's disease. More strikingly, hypoxia potentiated Ca2+ influx specifically through L-type Ca2+ channels in three distinct cellular systems. This effect was post-transcriptional, and evidence suggests it occurred via increased formation of amyloid peptides which alter Ca2+ channel trafficking via a mechanism involving increased production of reactive oxygen species by mitochondria. This action of hypoxia is likely to contribute to dysregulation of Ca2+ homeostasis, which has been proposed as a mechanism of cell death in Alzheimer's disease. We suggest, therefore, that our data provide a cellular basis to account for the known increased incidence of Alzheimer's disease in patients who have suffered prolonged hypoxic episodes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16321794      PMCID: PMC1569587          DOI: 10.1098/rstb.2005.1761

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  38 in total

1.  O2-sensitive K+ currents in carotid body chemoreceptor cells from normoxic and chronically hypoxic rats and their roles in hypoxic chemotransduction.

Authors:  C N Wyatt; C Wright; D Bee; C Peers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

2.  Hypoxic enhancement of quantal catecholamine secretion. Evidence for the involvement of amyloid beta-peptides.

Authors:  S C Taylor; T F Batten; C Peers
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

Review 3.  The G.L. Brown Prize Lecture. Voltage-dependent calcium channels and their modulation by neurotransmitters and G proteins.

Authors:  A C Dolphin
Journal:  Exp Physiol       Date:  1995-01       Impact factor: 2.969

Review 4.  A new hypothesis for the mechanism of amyloid toxicity, based on the calcium channel activity of amyloid beta protein (A beta P) in phospholipid bilayer membranes.

Authors:  H B Pollard; E Rojas; N Arispe
Journal:  Ann N Y Acad Sci       Date:  1993-09-24       Impact factor: 5.691

5.  Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.

Authors:  C Peers; I Johnston; B Lang; D Wray
Journal:  Neurosci Lett       Date:  1993-04-16       Impact factor: 3.046

6.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Authors:  A Lorenzo; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Chronic obstructive pulmonary disease. An original model of cognitive decline.

Authors:  R A Incalzi; A Gemma; C Marra; R Muzzolon; O Capparella; P Carbonin
Journal:  Am Rev Respir Dis       Date:  1993-08

8.  Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study.

Authors:  T K Tatemichi; M Paik; E Bagiella; D W Desmond; Y Stern; M Sano; W A Hauser; R Mayeux
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

Review 9.  Altered gene expression in cerebral ischemia.

Authors:  K Kogure; H Kato
Journal:  Stroke       Date:  1993-12       Impact factor: 7.914

10.  Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells.

Authors:  R M Wightman; J A Jankowski; R T Kennedy; K T Kawagoe; T J Schroeder; D J Leszczyszyn; J A Near; E J Diliberto; O H Viveros
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more
  7 in total

1.  Hypoxia-inducible factor-1α regulates the expression of L-type voltage-dependent Ca(2+) channels in PC12 cells under hypoxia.

Authors:  Ran Li; Yong Wang; Zhaofei Yang; Yunling He; Tong Zhao; Ming Fan; Xuan Wang; Lingling Zhu; Xiaomin Wang
Journal:  Cell Stress Chaperones       Date:  2015-02-04       Impact factor: 3.667

2.  Hypoxia enhances high-voltage-activated calcium currents in rat primary cortical neurons via calcineurin.

Authors:  Kun Xiang; Damien Earl; Trisha Dwyer; Brian L Behrle; Elizabeth I Tietz; L John Greenfield
Journal:  Epilepsy Res       Date:  2012-01-13       Impact factor: 3.045

Review 3.  Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels.

Authors:  Florian Veit; Oleg Pak; Ralf P Brandes; Norbert Weissmann
Journal:  Antioxid Redox Signal       Date:  2015-02-20       Impact factor: 8.401

4.  trans-Resveratrol protects ischemic PC12 Cells by inhibiting the hypoxia associated transcription factors and increasing the levels of antioxidant defense enzymes.

Authors:  Megha Agrawal; Vivek Kumar; Abhishek K Singh; Mahendra P Kashyap; Vinay K Khanna; Maqsood A Siddiqui; Aditya B Pant
Journal:  ACS Chem Neurosci       Date:  2012-11-09       Impact factor: 4.418

5.  Hypoxic modulation of ca(2+) signaling in human venous and arterial endothelial cells.

Authors:  P K Aley; C C Bauer; M L Dallas; J P Boyle; K E Porter; C Peers
Journal:  J Membr Biol       Date:  2009-01-09       Impact factor: 1.843

6.  Impaired pattern separation in Tg2576 mice is associated with hyperexcitable dentate gyrus caused by Kv4.1 downregulation.

Authors:  Kyung-Ran Kim; Yoonsub Kim; Hyeon-Ju Jeong; Jong-Sun Kang; Sang Hun Lee; Yujin Kim; Suk-Ho Lee; Won-Kyung Ho
Journal:  Mol Brain       Date:  2021-03-30       Impact factor: 4.041

Review 7.  Hydrogen Ion Dynamics as the Fundamental Link between Neurodegenerative Diseases and Cancer: Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis on Multiple Sclerosis.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stephan J Reshkin; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.